There were no significant differences regarding baseline characteristics between both groups except for the prevalence of peripheral artery disease and the intake of Sodium-Glucose Transport Protein 2 (SGLT2) inhibitors. This evidence concerns the gene SLC5A2 and peripheral arterial disease.